Ovarian Cancer IMPACT Act
The source supplies the latest action, but no lifecycle stage.
Latest action (24 Sep 2026): Referred to the House Committee on Energy and Commerce.
What this bill does
This bill, H.R. 10544, titled "To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes," has been introduced in the House of Representatives by Representative Rosa DeLauro. Its stated purpose is to enhance federal initiatives related to ovarian cancer.
Specifically, the bill aims to improve public awareness of ovarian cancer and support systems for assessing hereditary cancer risks. It also seeks to broaden access to genetic counseling and testing, as well as to specialized medical care for individuals. The full details of how these goals would be achieved are not yet publicly available as the official text of the bill has not been published.
H.R. 10544 is currently at the introduction stage, meaning it has just been formally presented to Congress. For the bill to advance, it would typically need to be considered by relevant committees, potentially undergo amendments, and then be voted on by the House and subsequently the Senate.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
24 Sep 2026
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 10544 do?
- This bill, H.R. 10544, titled "To modernize and strengthen Federal efforts to improve ovarian cancer awareness, hereditary cancer risk assessment, access to genetic counseling and testing, and access to specialty care, and for other purposes," has been introduced in the House of Representatives by Representative Rosa DeLauro. Its stated purpose is to enhance federal initiatives related to ovarian cancer. Specifically, the bill aims to improve public awareness of ovarian cancer and support systems for assessing hereditary cancer risks. It also seeks to broaden access to genetic counseling and testing, as well as to specialized medical care for individuals. The full details of how these goals would be achieved are not yet publicly available as the official text of the bill has not been published. H.R. 10544 is currently at the introduction stage, meaning it has just been formally presented to Congress. For the bill to advance, it would typically need to be considered by relevant committees, potentially undergo amendments, and then be voted on by the House and subsequently the Senate.
- Has H.R. 10544 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10544. Check the latest action and official source below.
- Who sponsored H.R. 10544?
- H.R. 10544 was sponsored by Rep. DeLauro, Rosa L. [D-CT-3] (D-CT), with 4 cosponsors.
- What's the latest action on H.R. 10544?
- Referred to the House Committee on Energy and Commerce. (24 Sep 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Lower Premiums, Faster Payments Act
340B Rebate Model Delay Act
More bills from Rep. DeLauro, Rosa L. [D-CT-3]
Supporting the designation of September 2026 as "National Ovarian Cancer Awareness Month".
Calling for a trade policy that supports workers, consumers, independent farmers, small businesses, and the environment.
We Need Eviction Data Now Act of 2021
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.